Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
Lu Lu,1 Yue Ding,2 Yong Zhang,2 Rodney JY Ho,3 Yuan Zhao,4 Tong Zhang,1 Chunrong Guo2 1School of Pharmacy, 2Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 3Department of Pharmaceutics, University of Washington, Seattle, WA, USA; 4C...
Enregistré dans:
Auteurs principaux: | Lu L, Ding Yue, Zhang Y, Ho RJY, Zhao Y, Zhang T, Guo C |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8d06d0ccec064df6a0466efd19e67947 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer
par: Zhang L, et autres
Publié: (2021) -
Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity
par: Han B, et autres
Publié: (2020) -
In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications
par: Hua S, et autres
Publié: (2019) -
Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome–Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes
par: Petrini M, et autres
Publié: (2021) -
In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
par: Ashrafzadeh MS, et autres
Publié: (2020)